Navigation Links
Anthera Provides Corporate Update on Recent Activities
Date:3/15/2012

HAYWARD, Calif., March 15, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today provided an update on company events following the recent termination of the VISTA-16 clinical study.

Immediately after the VISTA-16 Data Safety Monitoring Board (DSMB) recommended halting the clinical study, the Company took steps to cease patient enrollment and dosing. Redundant levels of written communication were sent to the investigators and clinical sites involved in the study to immediately cease enrollment and to withdraw all enrolled patients. The Company will be conducting final patient follow-up visits within the coming weeks.

The Company has taken immediate action to decrease operating expenses through a reduction or elimination of vendor activities and immediate headcount reductions. This will result in an elimination of approximately 45% of Anthera's headcount. These combined actions allow for the reallocation of resources to other potential development programs and product portfolio efforts.

Development of blisibimod (A-623) continues to progress according to plan. The PEARL-SC study, which completed enrollment in the fourth quarter of 2011, is examining the therapeutic benefit of monthly and weekly subcutaneous administration of blisibimod in SLE patients. The primary endpoint of the PEARL-SC study is clinical improvement at 24 weeks in an SLE responder index. The study remains on track to produce top-line efficacy data in the second quarter of 2012.

In addition, the PEARL-SC open-label extension (OLE) study continues to enroll patients. All patients who participated in the PEARL-SC study are eligible for rollover into the OLE clinical study.

About Anthera Pharmaceuticals

Anthera Pharmaceutica
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
2. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
3. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
4. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
5. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
6. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
7. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
10. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
11. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015   The New York Times ... internationally acclaimed plastic surgeon, Dr. Rod Rohrich . ... is proven to reduce fat deposits under the chin. ... The active ingredient in Kybella, deoxycholic acid, dissolves ... the ability to reshape this area without surgery. "So ...
(Date:5/4/2015)... -- Former NASA scientist Tamim Hamid was ... discussed Theradome™, the first portable and wearable OTC hair ... firsthand how, via laser technology, Theradome™ offers individuals a ... not require surgery or medication.  "The ... the hair follicle, which is where the stem cells ...
(Date:5/4/2015)... GREENWICH, Conn. , May 4, 2015 ... middle market private equity firm, announced today ... its portfolio company, BioPharm Communications. BioPharm specializes in ... marketing programs for the pharmaceutical and biotechnology ... Capital repaid to its shareholders half of ...
Breaking Medicine Technology:Dr. Rod Rohrich Provides Medical Expertise on Kybella 2Dr. Rod Rohrich Provides Medical Expertise on Kybella 3FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2Southfield Capital and BioPharm Communications Announce Dividend Recapitalization 2
... week at the International Federation of Clinical Chemistry Congress ... threshold for troponin improves clinical outcomes and patient survival ... a protein found inside of heart cells that is ... blood supply.   Cardiac troponin is regarded ...
... PITTSBURGH, May 18, 2011 Neuro Kinetics, Inc. ... diagnostic equipment used worldwide for neuro-physiologic, neuro-otologic, vestibular ... released version 6.10 of its VEST™ control and ... I-Portal® devices and VEST software to conduct vestibular, ...
Cached Medicine Technology:Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 2Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 3Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay 4Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software 2
(Date:5/4/2015)... PROVIDENCE, R.I. (PRWEB) May 04, 2015 Johnson ... new $40 million engineering and science academic center on Wednesday, ... in the ground for land made available by the re-alignment ... at the corner of Friendship and Chestnut streets in Providence, ... being built on a parcel of land the university purchased ...
(Date:5/4/2015)... Ana, CA (PRWEB) May 04, 2015 The ... live a full life are the motivating forces behind The ... California clinical psychologist and author Amy L. Stark. , The ... the little girl next door comes from Stark’s desire to ... Stark. “I’ve been a fairy godmother to my neighbors’ children ...
(Date:5/4/2015)... 04, 2015 Now in its seventh ... leaders who have made outstanding contributions to the company, ... both in acute and post-acute care settings. The five ... Provider of the Year, Advanced Practice Clinician of the ... of the Year. Recipients are selected by IPC’s senior ...
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... in Charlottesville, VA. McCartney is one of the most ... this beloved performer continues to roll along with no signs ... legendary groups: Wings and The Beatles, has been celebrating his ... the “Out There” tour and has continually added new stops ...
(Date:5/4/2015)... Diego, CA (PRWEB) May 04, 2015 ... a ribbon cutting ceremony at their brand new, 13,700 ... this year. The new building will not only provide ... population, but will also offer community and educational events ... The new facility is located next door to their ...
Breaking Medicine News(10 mins):Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3Health News:Paul McCartney Tickets at John Paul Jones Arena in Charlottesville, VA: Ticket Down Slashes Paul McCartney Ticket Prices in Charlottesville at the John Paul Jones Arena 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3
... , CHICAGO and RALEIGH, N.C., Aug. ... focused exclusively on the awareness, testing and conversation of ... transmitted infection (STI) education and advocacy organization is now ... , , Since 1914, the ...
... , , SANTA MONICA, Calif., ... Kent Conrad (D-ND) and a number of Senate conservatives have been ... they would not have the market clout to leverage discounts and ... a path to gutting state consumer protection laws, according to the ...
... Decline seen as sign of progress against drug-resistant ... Prescribing antibiotics to treat respiratory tract infections has ... has found. , That,s mainly the result of ... according to the researchers. But despite a decline ...
... Gardasil, study finds, , TUESDAY, Aug. 18 (HealthDay News) ... a cause of cervical cancer, appears safe, with relatively ... government study. , The study, which included data ... found that the rate of serious adverse events for ...
... ... automating claims processing with Corticon Business Rules Platform , ... Redwood City, CA (PRWEB) August 18, 2009 -- Corticon Technologies ... project: American Community Mutual Insurance Company® (ACMIC) has gone live with an ...
... , , , ... and Aging has released "Technologies To Help Older Adults Maintain ... technology areas with significant potential of improving chronic health care ... care costs. , , "Spending on ...
Cached Medicine News:Health News:Confidential Online STD Testing Clinic, GetSTDTested.com, Strengthens Partnership With ASHA in the Fight Against STDs 2Health News:Confidential Online STD Testing Clinic, GetSTDTested.com, Strengthens Partnership With ASHA in the Fight Against STDs 3Health News:Sen. Conrad's Health Insurance Co-Ops Won't Provide Affordable Care and Could be Used by the Insurance Industry Against Americans, Says Consumer Watchdog 2Health News:Sen. Conrad's Health Insurance Co-Ops Won't Provide Affordable Care and Could be Used by the Insurance Industry Against Americans, Says Consumer Watchdog 3Health News:Sen. Conrad's Health Insurance Co-Ops Won't Provide Affordable Care and Could be Used by the Insurance Industry Against Americans, Says Consumer Watchdog 4Health News:Antibiotics Being Prescribed Less for Respiratory Infections 2Health News:Antibiotics Being Prescribed Less for Respiratory Infections 3Health News:Cervical Cancer Vaccine Seems Safe 2Health News:Cervical Cancer Vaccine Seems Safe 3Health News:American Community Mutual Insurance Company (ACMIC) Selects Corticon 2Health News:American Community Mutual Insurance Company (ACMIC) Selects Corticon 3Health News:American Community Mutual Insurance Company (ACMIC) Selects Corticon 4Health News:Center for Technology and Aging Brief Reviews Technologies That Improve Chronic Care and Help Older Adults Maintain Independence 2Health News:Center for Technology and Aging Brief Reviews Technologies That Improve Chronic Care and Help Older Adults Maintain Independence 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: